Abdullah Abbasi

Dr. Abdullah Abbasi

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in United European Gastroenterology Journal
Verified
Journal Article
Open access
KSKeith Siau
Keith Siau
JHJames Hodson
James Hodson
RIRichard Ingram
Richard Ingram
ABAndrew Baxter
Andrew Baxter
MWMonika M Widlak
Monika M Widlak
GMGiles Major
Giles Major
Background: Endoscopy within 24 h of admission (early endoscopy) is a quality standard in acute upper gastrointestinal bleeding (AUGIB). We aimed to audit time to endoscopy outcomes and identify factors affecting delayed endoscopy (>24 h of admission).Methods: This prospective multicentre audit enrolled patients admitted with AUGIB who underwent inpatient endoscopy between November and December 2017. Analyses were performed to identify factors associated with delayed endoscopy, and to compare patient outcomes, including length of stay and mortality rates, between early and delayed endoscopy groups.Results: Across 348 patients from 20 centres, the median time to endoscopy was 21.2 h (IQR 12.0–35.7), comprising median admission to referral and referral to endoscopy times of 8.1 h (IQR 3.7–18.1) and 6.7 h (IQR 3.0–23.1), respectively. Early endoscopy was achieved in 58.9%, although this varied by centre (range: 31.0–87.5%, p = 0.002). On multivariable analysis, lower Glasgow–Blatchford score, delayed referral, admissions between 7:00 and 19:00 hours or via the emergency department were independent predictors of delayed endoscopy. Early endoscopy was associated with reduced length of stay (median difference 1 d; p = 0.004), but not 30‐d mortality (p = 0.344).Conclusions: The majority of centres did not meet national standards for time to endoscopy. Strategic initiatives involving acute care services may be necessary to improve this outcome.

29 February 2012 in AJOB Primary Research
Verified
Journal Article
Closed access
QQQuratul Ain Qaiser
Quratul Ain Qaiser
MIMobeen Iqbal
Mobeen Iqbal
AAAbdullah Abbasi
Abdullah Abbasi
AFAhmed Feroz
Ahmed Feroz
Background: As the focus of medical education shifts from factual learning to a more holistic approach for physician training, we need to concentrate more upon the ethical and moral development of medical students. The purpose of this study was to assess the level of moral development in first-year medical students. Methods: We used the Defining Issues Test (DIT-1) to assess moral development levels among newly entering first- year medical students at a medical school in Rawalpindi, Pakistan. The test was administered to 250 students, out of which 130 responses were included in the final analysis. Results: The mean age of the students was 18.6 ± 0.7 years. We found that only 16% of the students scored a “high” level of moral development based on the DIT. Conclusion: There may be several reasons for the low moral development scores in our cohort, but these findings make a strong case for future research and possible educational interventions in Pakistani medical schools.

31 May 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
YHYaqza Hussain
Yaqza Hussain
ABAyman Bannaga
Ayman Bannaga
NFNeil Fisher
Neil Fisher
AKAshwin Krishnamoorthy
Ashwin Krishnamoorthy
PKPeter Kimani
Peter Kimani
RARamesh Arasaradnam
Ramesh Arasaradnam
Background: Hepatocellular cancer (HCC) is associated with high mortality, and early diagnosis leads to better survival. Patients with cirrhosis, especially due to nonalcoholic fatty liver disease and viral hepatitis, are at higher risk of developing HCC and form the main screening group. The current screening methods for HCC (6-monthly screening with serum alpha fetoprotein and ultrasound liver) have low sensitivity; hence, there is a need for better screening markers for HCC. Objective: Our study, TENDENCY, aims to validate the novel screening markers (methylated septin 9, urinary volatile organic compounds, and urinary peptides) for HCC diagnosis and study these noninvasive biomarkers in liver disease. Methods: This is a multicenter, nested case-control study, which involves comparing the plasma levels of methylated septin 9 between confirmed HCC cases and patients with cirrhosis (control group). It also includes the comparison of urine samples for the detection of HCC-specific volatile organic compounds and peptides. Based on the findings of a pilot study carried out at University Hospital Coventry & Warwickshire, we estimated our sample size to be 308 (n=88, 29% patients with HCC; n=220, 71% patients with cirrhosis). Urine and plasma samples will be collected from all participants and will be frozen at –80 °C until the end of recruitment. Gas chromatography–mass spectrometry will be used for urinary volatile organic compounds detection, and capillary electrophoresis–mass spectrometry will be used for urinary peptide identification. Real-time polymerase chain reaction will be used for the qualitative detection of plasma methylated septin 9. The study will be monitored by the Research and Development department at University Hospital Coventry & Warwickshire. Results: The recruitment stage was completed in March 2023. The TENDENCY study is currently in the analysis stage, which is expected to finish by November 2023. Conclusions: There is lack of effective screening tests for hepatocellular cancer despite higher mortality rates. The application of more sensitive plasma and urinary biomarkers for hepatocellular cancer screening in clinical practice will allow us to detect the disease at earlier stages and hence, overall, improve HCC outcomes. International Registered Report Identifier (IRRID): DERR1-10.2196/44264

1 December 2025 in Pancreatology
Verified
Journal Article
Closed access
AAAbdullah Abbasi
Abdullah Abbasi
RARaheel Anjum
Raheel Anjum
PTPavit Tewatia
Pavit Tewatia
SMShyam Menon
Shyam Menon

9 July 2025 in Current Treatment Options in Gastroenterology
Verified
Journal Article
Open access
PDF file
AAAbdullah Abbasi
Abdullah Abbasi
SCSaurabh Chandan
Saurabh Chandan
SPSagar Pathak
Sagar Pathak
DYDennis Yang
Dennis Yang
MAMustafa A. Arain
Mustafa A. Arain
Section Purpose of Review Endoscopic Ultrasound guided Gall Bladder drainage (EUS-GBD) is a useful tool in management of various gall bladder related pathologies. While the initial use was limited for non-surgical patients with acute cholecystitis, recent data has shown ever expanding indications. The purpose of this review article is to explore recent literature behind EUS-GBD and its role in treatment algorithm of various conditions. AbstractSection Recent Findings In non-surgical candidates with acute cholecystitis, EUS-GBD has better clinical efficacy and safety profile compared with endoscopic trans-papillary gallbladder drainage (ETP-GBD) or percutaneous cholecystostomy tube placement for gallbladder drainage (PCT-GBD). There is increasing evidence that EUS-GBD can be a suitable option for patients’ acute cholecystitis who are candidates for interval cholecystectomy. While there is promising data for use of EUS-GBD for malignant bile duct obstruction (MBDO) in patent cystic duct, its true utility is yet to be seen. Case series and animal studies show future promises of EUS-GBD for cholecystolithotomy and gall bladder polyp resection. AbstractSection Summary Endoscopic Ultrasound guided Gall Bladder drainage (EUS-GBD) is safe and effective options for non-surgical patients with acute cholecystitis. Based on local expertise and case, it can be considered for MBDO or acute cholecystitis patients who are candidates for interval cholecystectomy.

11 August 2025 in International Journal of Gastrointestinal Intervention
Verified
Journal Article
Open access
PDF file
AAAbdullah Abbasi
Abdullah Abbasi
SJSalmaan Jawaid
Salmaan Jawaid
PBPetros Benias
Petros Benias
MHMuhammad Hasan
Muhammad Hasan
MKMai Khalaf
Mai Khalaf
DYDennis Yang
Dennis Yang
Abdullah Abbasi, Salmaan Jawaid, Petros Benias, Muhammad Khalid Hasan, Mai Khalaf, Peter Vassilev Draganov, and Dennis Yang. Int J Gastrointest Interv -0001;0:. https://doi.org/10.18528/ijgii250056